Antibiotics Market Size Worth USD 71.75 Billion in 2032 | Emergen Research

Increasing rate of infectious diseases, development of innovative products, and rising usage of antibiotics are major factors driving Antibiotics Market revenue growth

Vancouver, Dec. 26, 2023 (GLOBE NEWSWIRE) — The global antibiotics market size was USD 42.32 Billion in 2022 and is expected to register a rapid revenue CAGR of 5.5% during the forecast period. The global antibiotics market is witnessing significant growth, driven by factors such as the increasing rate of infectious diseases, development of innovative products, and rising antibiotic usage. A study published in September 2022 by the Lancet Regional Health-Southeast Asia revealed that azithromycin 500mg tablets were the most frequently used antibiotics in India. However, despite this growth, challenges like antibiotic resistance and high research costs pose potential restraints.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @  https://www.emergenresearch.com/request-sample/2591

Key Market Trends:

Antibiotic Usage and Market Drivers:

Antibiotics play a crucial role in treating bacterial infections in humans and animals, contributing to the market’s revenue growth.

The CDC reports 7,174 new cases of Tuberculosis (TB) in the U.S. in 2020, highlighting the ongoing need for effective antibiotic treatments.

Pharmaceutical companies focus on developing combination medicines to address antibiotic-resistant illnesses, fostering market innovation.

Market Challenges:

Rising antibiotic resistance poses a significant threat, leading to longer hospital stays, increased medical costs, and higher mortality rates.

The high cost of trials, research, and the stringent approval process, such as the increased cost of Abbreviated New Drug Approval (ANDA) by the FDA, may hinder market growth.

Product Insights:

Penicillin Segment Dominates:

In 2022, the penicillin segment held the largest revenue share, driven by increased awareness and improved healthcare infrastructure.

Better identification and treatment of bacterial infections, especially respiratory tract illnesses, contribute to the segment’s growth.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @

https://www.emergenresearch.com/request-discount/2591

Cephalosporin Segment:

The cephalosporin segment is expected to register moderate growth, fueled by rising infectious diseases, R&D efforts, and increased financing for antibiotic development.

Route of Administration Insights:

Parenteral Segment Leads:

The parenteral segment is expected to dominate the market due to the increasing number of hospital admissions for infectious diseases.

Prolonged hospital stays contribute to higher infection rates, driving the revenue growth of parenteral antibiotics.

Oral Segment Growth:

The oral segment is expected to witness the fastest revenue growth, attributed to the effective oral administration of antibiotics, reduced side effects, and cost advantages.

Application Insights:

Respiratory Infections Lead:

The respiratory infections segment is poised to hold the largest revenue share, driven by the rising prevalence of chronic respiratory disorders globally.

Initiatives like the Global Alliance against Chronic Respiratory Diseases aim to address these conditions, influencing market growth.

Urinary Infections Growth:

The urinary infection segment is expected to register steady growth, fueled by pharmaceutical firms developing antibiotics to tackle multi-drug-resistant bacteria.

End-Use Insights:

Hospitals Pharmacies Dominate:

Hospital pharmacies are expected to account for a large revenue share, driven by the availability of broad-spectrum antibiotics and the implementation of antibiotic usage control policies.

Retail Pharmacies:

Retail pharmacies play a crucial role but are anticipated to have a smaller market share compared to hospital pharmacies.

Regional Insights:

North America Leads:

North America accounted for the largest revenue share in 2022, driven by the prevalence of infectious diseases, aging populations, and the presence of key market players.

The CDC reports high cases of TB and pneumonia, contributing to the demand for antibiotics in the region.

Asia Pacific Growth:

The Asia Pacific market is expected to witness the fastest growth, driven by digital imaging adoption, a vast population, and increasing innovation in infectious disease treatments.

Europe’s Strong Market Presence:

Europe is anticipated to have a considerably large revenue share, supported by the rising prevalence of infectious diseases and a favorable regulatory environment.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @

https://www.emergenresearch.com/select-license/2591

Scope of Research

Major Companies and Competitive Landscape

The global antibiotics market is fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing testing, and introducing more effective antibiotics  solutions in the market. Some major players included in the global antibiotics market report are:

• Bristol-Myers Squibb Company
• AstraZeneca
• The Menarini Group 
• Otsuka America Pharmaceutical, Inc. 
• GSK plc
• Bayer AG
• Lilly
• Merck KGaA
• Johnson & Johnson Services, Inc.
• Novartis AG
• Pfizer Inc.
• Abbott
• Sanofi
• F. Hoffmann-La Roche Ltd.
• AbbVie Inc.
• Teva Pharmaceutical Industries Ltd.
• Cipla Inc.
• Lupin

Strategic Development

•  
• On 19 September, 2023, SIRIO introduced a new line of consumer health gummies at CPHI Barcelona. The newly launched herbal gummies cater to popular consumer health categories. These three innovative formulations aim to facilitate the growth of SIRIO’s partners, particularly pharmaceutical and Over-The-Counter (OTC) brands looking to establish a presence in the active health sector. The products are tailored to support customers in trending consumer health areas such as ‘cough and cold’, ‘oral care’, and ‘Urinary Tract Infections’ (UTI).
• On April 15, 2023, GSK unveiled favorable outcomes from the significant EAGLE-2 and EAGLE-3 phase III trials concerning gepotidacin, a pioneering oral antibiotic with a unique mode of action designed for treating uncomplicated UTI in female adults and adolescents. These findings were presented today in an oral session at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) held in Copenhagen, Denmark.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@

https://www.emergenresearch.com/industry-report/antibiotics-market

Emergen Research has segmented the global antibiotics market on the basis of product, route of administration, drug origin, and spectrum of activity component, delivery mode, end-use, and region

• Product Outlook (Revenue, USD Billion; 2019-2032)

• • Penicillin
  • Cephalosporin
  • Carbapenems
  • Monobactams
  • Quinolones
  • Macrolides
  • Others

•  Route of Administration (Revenue, USD Billion; 2019-2032)

• • Oral
  • Parenteral

• Drug Origin Outlook (Revenue, USD Billion; 2019-2032)

• • Natural
  • Semisynthetic
  • Synthetic

• Spectrum of Activity Outlook (Revenue, USD Billion; 2019-2032)

• • Broad-Spectrum Antibiotic
  • Narrow-Spectrum Antibiotic

• Application Outlook (Revenue, USD Billion; 2019-2032)

• • Skin Infections
  • Ear Infections
  • Urinary Infections
  • Respiratory Infections
  • Others

• End-Use Outlook (Revenue, USD Billion; 2019-2032)

• • Hospital Pharmacies
  • Retail Pharmacies
  • Others

• Regional Outlook (Revenue, USD Billion; 2019–2032)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. France
    3. UK
    4. Italy
    5. Spain
    6. Benelux
    7. Rest of Europe
  • Asia Pacific
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. UAE
    3. South Africa
    4. Turkey
    5. Rest of Middle East & Africa

Curated Reports You Shouldn’t Miss: Dive In Now!

Medical Aesthetics Market, By Product, By Procedure (Surgical Procedures and Non-Surgical Procedures), By End-Use (Clinics, Hospitals, and Medical Spas, Beauty Centers, Home Care Settings), and By Region Forecast to 2032

Needles Market, By Product (Suture, Blood Collection, Ophthalmic, Dental, Insufflation, Pen, Biopsy and Aspiration Needles and Others), By Type, By Application, By Delivery Mode, By Material, By End-Use, and By Region Forecast to 2032

Dental Bone Graft Market, By Type of Graft Material (Autografts, Allografts, Xenografts, and Synthetic Bone Grafts), By Application, By Mechanism, By Material Form, By End-Use, and By Region Forecast to 2032

Ovarian Cancer Drugs Market, By Treatment Type, By Route of Administration (Oral, Parental, and Others, By Cancer Type, By Distribution Channels, By End-Use (Hospitals, Homecare, Specialty Centers, and Others), and By Region Forecast to 2032

Steam Autoclave Market, By Product (Tabletop Steam Autoclaves, Vertical Steam Autoclaves, Floor Standing Steam Autoclaves, Horizontal Steam Autoclaves, and Others), By Technology, By End-Use, and By Region Forecast to 2032

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights